Navigation Links
Sea Creature's Toxin Could Lead to Promising Cancer Treatment

A toxin derived from a reclusive sea creature resembling a translucent doughnut has inspired UT Southwestern Medical Center researchers to develop //a related compound that shows promise as a cancer treatment.

In a study appearing online this week in the Proceedings of the National Academy of Sciences, the UT Southwestern scientists detail how the toxin blocks uninhibited reproduction of cultured human cancer cells while leaving healthy cells unaffected.

An accompanying study in PNAS shows that, in pre-clinical trials, a synthetic form of the toxin reduced human tumors implanted in mice without the harmful side effects seen using other cancer drugs. “Diazonamide is a special molecule – it’s teaching us more than we imagined,” said Dr. Patrick Harran, professor of biochemistry and a senior author on both studies.

“This is a truly exciting result,” said Dr. John Schwab, a program officer at the National Insti tutes of Health’s National Institute of General Medical Sciences, which partly funded the work. “Not only has this UT Southwestern team identified a potent anti-cancer drug, but its unique mode of action avoids the kinds of side effects that make cancer chemotherapy so difficult. It’s a great example of how NIH support for fundamental chemical research can benefit the American health-care consumer.”

The animal, Diazona angulata, is a sea squirt a few inches wide that lives in colonies anchored to rocks. It was discovered offshore of the Philippines in 1990 as scientists were looking for species that might lead to useful drugs. From a few specimens, scientists extracted a tiny amount of a toxin, diazonamide A, which the animal probably uses to repel predators.

The toxin proved to kill cancer cells in culture, but so little of its natural form was available that a race soon began to synthesize it in the laboratory.

A chemical structure for diazonamide A was published in 1991, but in 2001, Dr.
'"/>




Page: 1 2 3

Related medicine news :

1. Toxins linked with pregnancy loss
2. Toxin connected to Flesh-eating Pneumonia in Kids
3. Vegetables decrease Tobacco Toxins
4. Toxin injections support stroke associated spasticity
5. Indians Stay Away from Coke, Pepsi After Toxin Scare
6. Toxin from the sea to relieve pain
7. Toxin Identified For Alzheimer’s Diseas
8. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
9. Gold Nanoparticles Are Good Detectors Biological Toxins
10. Appearance Of Facial Scars Improved By Botulinum Toxin
11. "Beach to Bedside" Study Focuses on Effects of Inhaled Toxins
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 2Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 3Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 4Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 5Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Pioneer 28R 29 Surgical Technology Inc Receives Prestigious Spine Technology Awards 6722 1Pioneer 28R 29 Surgical Technology Inc Receives Prestigious Spine Technology Awards 6722 2Upsher Smith Announces Milestone in Development of CNS Strategy 6718 1Upsher Smith Announces Milestone in Development of CNS Strategy 6718 2Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 1Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 2Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 3
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2